Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Not yet recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 242Lymphoma 237Lymphoma, Non-Hodgkin 206Leukemia, Lymphocytic, Chronic, B-Cell 186Lymphoma, Large B-Cell, Diffuse 179Lymphoma, Follicular 175Lymphoma, B-Cell 113Lymphoma, Mantle-Cell 107Hodgkin Disease 105Leukemia, Myeloid, Acute 102Recurrence 98Multiple Myeloma 92Burkitt Lymphoma 90Leukemia 78Neoplasms 68Lymphoma, B-Cell, Marginal Zone 60Hematologic Neoplasms 59Myelodysplastic Syndromes 56Waldenstrom Macroglobulinemia 48Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 43Lymphoma, T-Cell 43Lymphoma, T-Cell, Peripheral 36Lymphoma, T-Cell, Cutaneous 31Leukemia, Biphenotypic, Acute 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Leukemia, B-Cell 27Mycosis Fungoides 25Lymphoma, Large-Cell, Anaplastic 25Sarcoma 24Breast Neoplasms 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hepatic Insufficiency × Lymphoid × 90 days × Clear all
NCT07559474 2026-04-30

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Incyte Corporation

Phase 1 Not yet recruiting
16 enrolled
Lymphoid

Liver Diseases, Lymphoma, Follicular, Hepatic Insufficiency

NCT07550634 2026-04-24

Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment

MindRank AI Ltd

Phase 1 Not yet recruiting
32 enrolled
Lymphoid

Lymphoma, Follicular, Hepatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡